Key Events This Week
15 Sep: Stock closes at Rs.8,700.00, down 1.69% amid rating downgrade
16 Sep: Technical momentum shifts to mildly bullish with mixed indicator signals
17 Sep: Stock rebounds modestly to Rs.8,750.00 (+0.43%)
18 Sep: Week closes at Rs.8,770.25 (+0.23%)
15 September 2026: Downgrade to 'Buy' Amid Technical Softening
On 15 September, Apollo Hospitals closed at Rs.8,700.00, down 1.69% from the previous close of Rs.8,850.00. This decline coincided with MarketsMOJO’s downgrade of the stock’s rating from 'Strong Buy' to 'Buy'. The revision reflected a more cautious technical outlook despite the company’s robust fundamentals. Apollo Hospitals reported a return on capital employed (ROCE) of 17.13% for the latest quarter and a half-year ROCE of 17.41%, underscoring efficient capital utilisation. Net sales grew at an annualised rate of 16.82%, with operating profit surging 23.85%, and net profit rising 10.31% in the recent quarter, marking eleven consecutive quarters of earnings growth.
Valuation metrics remained attractive, with an enterprise value to capital employed ratio of 8.3 and a PEG ratio of 1.8. Institutional investors held a significant 65.44% stake, signalling confidence despite the technical downgrade. The stock traded closer to its 52-week high of Rs.9,326.80 but faced short-term resistance, reflected in the mild bearish signals from technical indicators such as the weekly MACD and KST oscillator.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
16 September 2026: Technical Momentum Shifts Amid Mixed Signals
The stock price remained at Rs.8,700.00 on 16 September, unchanged from the previous day’s close, but technical momentum showed a subtle shift from bullish to mildly bullish. The weekly MACD indicator turned mildly bearish, suggesting weakening short-term momentum, while the monthly MACD remained bullish, indicating a sustained longer-term uptrend. The Relative Strength Index (RSI) hovered in neutral territory on both weekly and monthly charts, signalling no clear overbought or oversold conditions.
The Know Sure Thing (KST) oscillator was mildly bearish weekly but bullish monthly, reinforcing the mixed technical picture. Daily moving averages remained mildly bullish, supporting a stabilising price trend. Bollinger Bands on weekly and monthly charts also indicated mild bullishness, suggesting contained volatility and a relatively stable trading range. However, On-Balance Volume (OBV) and Dow Theory analyses showed no definitive trend confirmation, reflecting market indecision.
Despite these mixed signals, Apollo Hospitals’ long-term performance remains strong, with a 10-year return of 578.44% compared to the Sensex’s 160.46%, and a year-to-date gain of 23.53% versus the Sensex’s decline of 13.16%. This divergence highlights the company’s resilience and sector leadership amid short-term technical caution.
17 September 2026: Modest Recovery on Improving Sentiment
On 17 September, the stock rebounded modestly, closing at Rs.8,750.00, up 0.43% from the previous day. This recovery aligned with the mildly bullish daily moving averages and the contained volatility suggested by Bollinger Bands. The volume increased to 58,570 shares, indicating renewed investor interest. The Sensex also gained 0.46%, closing at 35,439.31, reflecting a broadly positive market environment.
18 September 2026: Week Closes with Slight Gain Amid Mixed Technicals
The week concluded on 18 September with Apollo Hospitals closing at Rs.8,770.25, a 0.23% gain from the previous day. The Sensex rose 0.52% to 35,625.23. The stock’s volume declined to 25,549 shares, suggesting cautious trading ahead of the weekend. The technical indicators remained mixed, with the weekly MACD and KST oscillators still mildly bearish, but monthly indicators and moving averages supporting a constructive medium to long-term outlook.
Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Daily Price Performance: Apollo Hospitals vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-15 | Rs.8,700.00 | -1.69% | 35,169.62 | -1.69% |
| 2026-09-16 | Rs.8,712.95 | +0.15% | 35,276.25 | +0.30% |
| 2026-09-17 | Rs.8,750.00 | +0.43% | 35,439.31 | +0.46% |
| 2026-09-18 | Rs.8,770.25 | +0.23% | 35,625.23 | +0.52% |
Key Takeaways
Positive Signals: Apollo Hospitals maintains strong fundamental credentials with consistent earnings growth, robust ROCE above 17%, and attractive valuation metrics including a PEG ratio of 1.8. The stock’s long-term returns significantly outperform the Sensex, reflecting its dominant position in the hospital sector. Monthly technical indicators remain bullish, supporting a constructive medium to long-term outlook.
Cautionary Signals: The downgrade from 'Strong Buy' to 'Buy' and the shift in technical momentum to mildly bullish reflect a tempering of near-term price momentum. Weekly MACD and KST oscillators are mildly bearish, and volume-based indicators show no clear trend confirmation. The stock’s recent price action suggests a potential consolidation or mild correction phase.
Conclusion
Apollo Hospitals Enterprise Ltd’s week was characterised by a modest 0.90% decline, slightly underperforming the Sensex’s 0.41% fall. The downgrade to 'Buy' by MarketsMOJO amid technical softening signals a more cautious near-term outlook despite the company’s strong fundamentals and sector leadership. Mixed technical momentum indicators suggest a phase of consolidation, with short-term caution balanced by longer-term bullish trends. Investors should monitor evolving technical signals alongside ongoing financial performance to assess the stock’s directional trajectory within the healthcare sector’s broader growth narrative.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
